Similar articles

• Mass spectrometric determination of urinary prostaglandins in preterm infants. The basis for an effective and safe therapeutic regimen for the pharmacological closure.

  Seyberth HW, Müller H, Erlenmaier T, Mrongovius R. Seyberth HW, et al. Eur J Clin Pharmacol. 1980 Jul;18(1):89-93. doi: 10.1007/BF00561484. Eur J Clin Pharmacol. 1980. PMID: 7398753 No abstract available.
• Prostaglandins and the ductus arteriosus.

  [No authors listed] [No authors listed] Lancet. 1976 Oct 16;2(7990):837. Lancet. 1976. PMID: 61506 No abstract available.
• Prediction of Therapeutic Response to Cyclooxygenase Inhibitors in Preterm Infants with Patent Ductus Arteriosus.

  Hu Y, Jin H, Jiang Y, Du J. Hu Y, et al. Pediatr Cardiol. 2018 Apr;39(4):647-652. doi: 10.1007/s00246-018-1831-x. Epub 2018 Feb 21. Pediatr Cardiol. 2018. PMID: 29468349 Review.
• Plasma-prostaglandins in pre-term neonates before and after treatment for patient ductus arteriosus.

  Lucas A, Mitchell MD. Lucas A, et al. Lancet. 1978 Jul 15;2(8081):130-2. doi: 10.1016/s0140-6736(78)91510-6. Lancet. 1978. PMID: 78327
• [Prospects for the use of prostaglandins in pediatric cardiology].

  Zaorska B. Zaorska B. Kardiol Pol. 1981;24(2):167-72. Kardiol Pol. 1981. PMID: 6788996 Review. Polish. No abstract available.